MedLife S.A.

Regulatory Filings • May 17, 2023

No. 24 / 17 May 2023

To: BUCHAREST STOCK EXCHANGE

FINANCIAL SUPERVISORY AUTHORITY

CURRENT REPORT

Current report drafted according to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations

Report Date: 17 May 2023

Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")

Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania

Fax number: 0374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J40/3709/1996

Subscribed and paid-in share capital: 33,217,623 RON

Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report:

Correction of a clerical error regarding the Current Report published on 2 May 2023, IRIS code: C27C3

MED LIFE S.A. informs investors about the correction of a clerical error, presented in the Current Report dated 2 May 2023, IRIS code: C27C3, regarding the results of the share buyback program, which expired on 18 April 2023 and was conducted in accordance with the EGMS Resolution No. 2 as of 29 September 2021.

Thus, the total price paid for the repurchased shares (excluding brokerage fees and other acquisition costs) was presented in the previous Current Report with a value of RON 8,233,204.74, whereas the correct value is RON 8,233,188.14:

	2022	2023
Number of shares repurchased	382,134 shares	23,592 shares
Average buy-back price	RON 20.4961 / share	RON 16.9951 / share
Total price paid for the repurchased shares (excluding brokerage fees and other acquisition costs)	RON 8,233,188.14

Mihail Marcu Chief Executive Officer

________________